Bio Rad Laboratories Inc Quick Ratio (BIO) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Bio rad Laboratories Inc   (NYSE: BIO)

Bio Rad Laboratories Inc 's Quick Ratio

BIO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.92 a new company low.

Within Laboratory Analytical Instruments industry 12 other companies have achieved higher Quick Ratio than Bio Rad Laboratories Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1335 to 1898.

Explain Quick Ratio?
How much Cash & cash equivalents BIO´s has?
What are BIO´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BIO Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 168.52 % 179.97 % 55.63 % 53.16 % 11.6 %
Y / Y Cash & cash equivalent Change -35.44 % -5.76 % 12.12 % -12.86 % -15.28 %
Quick Ratio MRQ 0.92 1.78 1.88 2.92 3.84
BIO's Total Ranking # 1898 # 1335 # 632 # 81 # 777
Seq. Current Liabilities Change 9.14 % 83.16 % -0.95 % 35.61 % 13.8 %
Seq. Cash & cash equivalent Change -43.32 % 73.24 % -36.33 % 3.26 % -17.26 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 13
Healthcare Sector # 643
Overall Market # 1898


Quick Ratio Statistics
High Average Low
6.28 2.33 0.92
(Mar 31 2011)   (Jun 30 2026)




Financial Statements
Bio Rad Laboratories Inc 's Current Liabilities $ 961 Millions Visit BIO's Balance sheet
Bio Rad Laboratories Inc 's Cash & cash equivalent $ 887 Millions Visit BIO's Balance sheet
Source of BIO's Sales Visit BIO's Sales by Geography


Cumulative Bio Rad Laboratories Inc 's Quick Ratio

BIO's Quick Ratio for the trailling 12 Months

BIO Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 116.27 % 74.83 % 32.83 % 15 % -2.43 %
Y / Y Cash & cash equivalent TTM Growth -12.7 % -7.97 % -6.14 % -6.7 % -5.28 %
Quick Ratio TTM 1.7 2.39 3.27 3.58 4.21
Total Ranking TTM # 4076 # 2747 # 2428 # 3081 # 679
Seq. Current Liabilities TTM Growth 27.36 % 34.55 % 11.72 % 12.98 % 2.95 %
Seq. Cash & cash equivalent TTM Growth -9.26 % -1.79 % 1.86 % -3.83 % -4.34 %

Quick ratio ranking by company, industry and sector >> Back to BIO Financial Strength Comparisons >> Go to Compare BIO Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2026 to $961.30 millions, cumulative Quick Ratio decreased to 1.7 above the BIO average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Bio Rad Laboratories Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2747 to 4076.

Explain Quick Ratio?
How much Cash & cash equivalents BIO´s has?
What are BIO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 22
Healthcare Sector # 905
Within the Market # 4076


trailing twelve months Quick Ratio Statistics
High Average Low
1.54 0.95 0.67
(Sep 30 2011)   (Jun 30 2026)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Laboratory Analytical Instruments Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Quanterix Corporation  1.86 $ 93.529  Millions$ 50.373  Millions
Nautilus Biotechnology Inc   1.52 $ 13.166  Millions$ 8.639  Millions
Rapid Micro Biosystems Inc   1.13 $ 20.500  Millions$ 18.150  Millions
Bionano Genomics Inc   1.04 $ 10.420  Millions$ 10.039  Millions
Bio rad Laboratories Inc   0.92 $ 886.900  Millions$ 961.300  Millions
Precipio inc   0.83 $ 3.075  Millions$ 3.701  Millions
Lifeloc Technologies Inc   0.83 $ 0.908  Millions$ 1.099  Millions
Agilent Technologies inc   0.77 $ 1,758.000  Millions$ 2,289.000  Millions
Revvity Inc  0.67 $ 1,022.943  Millions$ 1,516.157  Millions
Harvard Bioscience Inc   0.26 $ 6.503  Millions$ 24.793  Millions
Waters Corporation  0.22 $ 539.000  Millions$ 2,399.000  Millions
Kewaunee Scientific Corporation  0.22 $ 10.261  Millions$ 47.235  Millions

Date modified: 2026-09-12T06:19:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.